A Phase 1-2, XIAP Antisense AEG35156 With Gemcitabine in Patients With Advanced Pancreatic Cancer

Clinical trial NCT00557596 · TERMINATED

Trial details

NCT number: NCT00557596
Sponsor: Aegera Therapeutics
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Carcinoma Pancreas

Start date: 2007-09-01
Primary completion: 2009-11-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.